Skip to content

Surrogates for blood pressure tracking in critical care setting

Surrogates for blood pressure tracking in critical care setting

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON19922
Enrollment
40
Registered
2019-11-22
Start date
2019-10-07
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular diseases

Interventions

None listed

Sponsors

Philips Electronics Nederland B.V.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients admitted to the ICU with arterial line as standard of care • Patients who undergo surgery (OR) with an arterial line as standard of care • Age >18 • Patients who give their consent for the investigation

Exclusion criteria

Exclusion criteria: • Neuro-trauma • Obesity (BMI>40) • Pregnancy • Delirium (diagnosed by hospital) • Significant language barrier that prevents the patient from understanding the Informed Consent

Design outcomes

Primary

MeasureTime frame
Investigation if surrogate parameters such as Pulse Arrival Time (PAT) can be used to track blood pressure changes.

Secondary

MeasureTime frame
Up to beat-to-beat tracking of blood pressure using initiated blood pressure surrogates in critical care patients in OR and ICU versus invasive blood pressure measurements.

Contacts

Public ContactMarjet Munsters

Philips

marjet.munsters@philips.com+310612345678

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)